Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Phospholipase C-induced lysosomal enzyme release refers to a cellular process in which the activation of phospholipase C (PLC) leads to the exocytosis of lysosomes and subsequent release of their enzymes into the extracellular space. This pathway is particularly relevant in immune cells such as monocytes and neutrophils, where it plays a role in inflammation, cytokine secretion (notably IL-1β), and other regulated secretory pathways.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Phospholipase C-Induced Lysosomal Enzyme Release Pathway (PLC-ILER).